The insulin-like growth factor-I plays a role in most functions of the body. it is produced by the liver, from where it reaches the circulation, and by most non-hepatic tissues where it acts locally. To study the roles of circulating versus paracrine effects of IGF-I we gene-deleted the IGF-I from the liver using the cre/loxP system. Thess mice showed a marked reduction in circulating IGF-I but no obvious phenotype. When they were crossed with mice with an acid labile subunit gene-deletion, the circulating levels fells further and these mice showed growth retardation and a reduction in bone density suggesting an important role for circulating """"""""endocrine"""""""" IGF-I. What remains to be determined are the roles for paracrine IGF-I. Liver IGF-I-deleted mice also showed a delayed onset and growth and metastases of an orthotopic colon cancer introduced by implanting the tumor onto the cecum. In a second model, DMBA -induced breast cancer and a gentically introduced breast cancer (SV40TAg mice) also showed delayed onset of tumor appearance, reduced growth and fewer tumors in the liver IGF-I-deleted mice. These results suggest that circulating IGF-I levels maybe important in the risk for cancer growth and metastases.
| Yakar, Shoshana; Pennisi, Patricia; Wu, Yiping et al. (2005) Clinical relevance of systemic and local IGF-I. Endocr Dev 9:11-6 |
| Yakar, Shoshana; Leroith, Derek; Brodt, Pnina (2005) The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 16:407-20 |
| Yakar, Shoshana; Pennisi, Patricia; Zhao, Hong et al. (2004) Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse. Novartis Found Symp 262:3-9; discussion 9-18, 265-8 |
| Yakar, Shoshana; Setser, Jennifer; Zhao, Hong et al. (2004) Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 113:96-105 |
| Wu, Yiping; Cui, Karen; Miyoshi, Keiko et al. (2003) Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res 63:4384-8 |
